NWDA WILL SCRUTINIZE STATE LEGISLATIVE, REGULATORY HEALTHCARE INITIATIVES, CHAIRMAN WHITMIRE SAYS; AMERISOURCE SHARING SCHERING SALES DATA DAILY
Executive Summary
The National Wholesale Druggists Association will be more closely tracking health care reform efforts at the state level in 1995-96, incoming Chairman Mel Whitmire (Cardinal) told the 1994 NWDA Annual Meeting Nov. 16 in Orlando, Fla. "The good news is that we managed to block unfavorable legislation at the federal level, but the bad news is that lack of a federal policy forces the states to act individually," Whitmire said.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth